logo

For the Inventor, By the Inventor

Stockholm, Sweden

Oncopeptides Ab

Calculating rank
USPTO Granted Patents = 10



Trademarks = 7

Forward Citations = 21

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Jack Spira (7 out of 10 patents)

silverMedal Fredrik Lehmann (7 out of 13 patents)

bronzeMedal Niklas Håkan Wahlström (1 out of 1 patent)

4.  Johan Anders Wennerberg (1 out of 1 patent)

5.  Rolf Larsson (1 out of 10 patents)

6.  Rolf Lewensohn (1 out of 1 patent)

7.  Joakim Gullbo (1 out of 1 patent)

8.  Hans Ehrsson (1 out of 1 patent)

9.  Kristina Luthman (1 out of 1 patent)

10.  Jakob Lindberg (1 out of 1 patent)

11.  Rolf Larsson (0 patent)

12.  Hans Ehrsson (0 patent)

13.  Niklas Håkan WAHLSTRÖM (0 patent)


10 patents:

1. 12396975 - Treatment of al amyloidosis with melflufen (2025-08-26),
2. 11896668 - Lyophilized preparation of cytotoxic dipeptides (2024-02-13),
3. 11344622 - Lyophilized preparation of cytotoxic dipeptides (2022-05-31),
4. 10869928 - Lyophilized preparation of cytotoxic dipeptides (2020-12-22),
5. 10543274 - Lyophilized preparation of cytotoxic dipeptides (2020-01-28),
6. 10322182 - Lyophilized preparation of cytotoxic dipeptides (2019-06-18),
7. 10287316 - Process for preparation of nitrogen mustard derivatives (2019-05-14),
8. 10285947 - Lyophilized preparations of melphalan flufenamide (2019-05-14),
9. 10285946 - Lyophilized preparations of melphalan flufenamide (2019-05-14),
10. 6992207 - Melphalan derivatives and their use as cancer chemotherapeutic drugs (2006-01-31),
Company Overview
Oncopeptides AB is a biotechnology company based in Stockholm, Sweden, focused on the development of innovative therapies for the treatment of hematological cancers. The company specializes in the research and commercialization of peptide-drug conjugates, leveraging its proprietary technology platform to create targeted treatments aimed at improving patient outcomes. Oncopeptides is committed to advancing its pipeline of drug candidates through rigorous clinical trials and collaborations, addressing unmet medical needs in oncology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

Oncopeptides Ab USPTO Patent Assignee Logo
10 Patents

#84 in Stockholm

#594 in Sweden

#56,100 in the World

Stockholm, SE
Stockholm, Sweden

Oncopeptides Ab

Forward Citations = 21

10 inventors:

goldMedal Jack Spira (7 out of 10 patents)

silverMedal Fredrik Lehmann (7 out of 13 patents)

bronzeMedal Niklas Håkan Wahlström (1 out of 1 patent)

4.  Johan Anders Wennerberg (1 out of 1 patent)

5.  Rolf Larsson (1 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oncopeptides Ab. Retrieved from https://idiyas.com/company/oncopeptides-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…